Kottayam: Suma Krishnan, a native of Kottayam, Kerala, has gained international recognition after being featured in the prestigious Forbes “50 Over 50” list. The honor celebrates women who have made significant contributions in their fields after the age of 50, highlighting Suma’s remarkable success in the biotechnology industry.
Now based in the United States, Suma Krishnan is the co-founder and president of Krystal Biotech, a company that has revolutionized the treatment of rare genetic disorders. Her pioneering work led to the development of Vyjuvek, the world’s first FDA-approved topical gene therapy, designed for patients suffering from dystrophic epidermolysis bullosa (DEB) a painful and life-altering skin disease that causes severe blistering and wounds.
Krishnan co-founded K

C News English

Sarasota Herald-Tribune Sports
The Columbian Life
The Daily Beast
The Hill